QUETIAPINE 400 mg/1 (Quetiapine TABLET, EXTENDED RELEASE) 400 mg/1

Quetiapine 400 mg extended-release tablets are an atypical antipsychotic medication used to manage certain mental health conditions. This extended-release formulation is designed for oral use and is manufactured by Macleods Pharmaceuticals Limited.

Strength

400 mg/1

Pack Size

500 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-137-15)

Manufacturer / TM Owner

Macleods Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Quetiapine is commonly used to treat symptoms of schizophrenia and bipolar disorder. It may also be prescribed for other conditions as determined by a healthcare provider. The extended-release formulation of quetiapine 400 mg is designed to provide a steady release of the medication over time, which can help manage symptoms throughout the day.

Side Effects

Quetiapine may cause drowsiness, dizziness, and dry mouth. Some users report weight gain and changes in blood sugar levels. It is important to monitor for any unusual side effects and consult a healthcare provider if they occur.

Precautions & Warnings

Quetiapine should be used with caution in individuals with a history of heart disease, low blood pressure, or seizures. It is important to follow the prescribed dosage and not to abruptly stop taking the medication without consulting a healthcare provider.

Avoid Interactions

Quetiapine may interact with other medications, including those that affect the central nervous system, such as alcohol and certain antidepressants. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions.

Frequently Asked Questions

Quetiapine is primarily used to manage symptoms of schizophrenia and bipolar disorder. It may also be prescribed for other conditions as determined by a healthcare provider.

Quetiapine extended-release tablets are designed to be taken orally, typically once daily. It is important to follow the dosage instructions provided by a healthcare provider.

Common side effects of quetiapine include drowsiness, dizziness, dry mouth, and weight gain. It is important to monitor for any unusual side effects and consult a healthcare provider if they occur.

Quetiapine may interact with other medications, including those that affect the central nervous system. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions.

If a dose of quetiapine is missed, it is important to follow the instructions provided by a healthcare provider. Typically, the missed dose should be taken as soon as possible, unless it is almost time for the next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.